IOVA
Price
$2.37
Change
+$0.02 (+0.85%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
932.87M
47 days until earnings call
Intraday BUY SELL Signals
PLX
Price
$2.06
Change
+$0.04 (+1.98%)
Updated
Jan 14, 04:59 PM (EDT)
Capitalization
165.67M
56 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

IOVA vs PLX

Header iconIOVA vs PLX Comparison
Open Charts IOVA vs PLXBanner chart's image
Iovance Biotherapeutics
Price$2.37
Change+$0.02 (+0.85%)
Volume$149.57K
Capitalization932.87M
Protalix BioTherapeutics
Price$2.06
Change+$0.04 (+1.98%)
Volume$3.67K
Capitalization165.67M
IOVA vs PLX Comparison Chart in %
View a ticker or compare two or three
VS
IOVA vs. PLX commentary
Jan 15, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IOVA is a Hold and PLX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 15, 2026
Stock price -- (IOVA: $2.38 vs. PLX: $2.06)
Brand notoriety: IOVA and PLX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IOVA: 63% vs. PLX: 80%
Market capitalization -- IOVA: $940.81M vs. PLX: $165.67M
IOVA [@Biotechnology] is valued at $940.81M. PLX’s [@Biotechnology] market capitalization is $165.67M. The market cap for tickers in the [@Biotechnology] industry ranges from $114.05B to $0. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IOVA’s FA Score shows that 1 FA rating(s) are green whilePLX’s FA Score has 0 green FA rating(s).

  • IOVA’s FA Score: 1 green, 4 red.
  • PLX’s FA Score: 0 green, 5 red.
According to our system of comparison, both IOVA and PLX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IOVA’s TA Score shows that 3 TA indicator(s) are bullish while PLX’s TA Score has 5 bullish TA indicator(s).

  • IOVA’s TA Score: 3 bullish, 7 bearish.
  • PLX’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, PLX is a better buy in the short-term than IOVA.

Price Growth

IOVA (@Biotechnology) experienced а -14.08% price change this week, while PLX (@Biotechnology) price change was +15.73% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.47%. For the same industry, the average monthly price growth was +3.44%, and the average quarterly price growth was +44.89%.

Reported Earning Dates

IOVA is expected to report earnings on Mar 03, 2026.

PLX is expected to report earnings on Mar 12, 2026.

Industries' Descriptions

@Biotechnology (+0.47% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IOVA($933M) has a higher market cap than PLX($166M). PLX YTD gains are higher at: 12.222 vs. IOVA (-13.919). PLX has higher annual earnings (EBITDA): 8.71M vs. IOVA (-363.95M). IOVA has more cash in the bank: 301M vs. PLX (29.4M). PLX has less debt than IOVA: PLX (8.18M) vs IOVA (52.5M). IOVA has higher revenues than PLX: IOVA (250M) vs PLX (61.8M).
IOVAPLXIOVA / PLX
Capitalization933M166M562%
EBITDA-363.95M8.71M-4,179%
Gain YTD-13.91912.222-114%
P/E RatioN/A25.75-
Revenue250M61.8M405%
Total Cash301M29.4M1,024%
Total Debt52.5M8.18M642%
FUNDAMENTALS RATINGS
IOVA vs PLX: Fundamental Ratings
IOVA
PLX
OUTLOOK RATING
1..100
5922
VALUATION
overvalued / fair valued / undervalued
1..100
22
Undervalued
74
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9761
PRICE GROWTH RATING
1..100
5746
P/E GROWTH RATING
1..100
10098
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IOVA's Valuation (22) in the Biotechnology industry is somewhat better than the same rating for PLX (74) in the Servicestothe Health Industry industry. This means that IOVA’s stock grew somewhat faster than PLX’s over the last 12 months.

IOVA's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as PLX (100) in the Servicestothe Health Industry industry. This means that IOVA’s stock grew similarly to PLX’s over the last 12 months.

PLX's SMR Rating (61) in the Servicestothe Health Industry industry is somewhat better than the same rating for IOVA (97) in the Biotechnology industry. This means that PLX’s stock grew somewhat faster than IOVA’s over the last 12 months.

PLX's Price Growth Rating (46) in the Servicestothe Health Industry industry is in the same range as IOVA (57) in the Biotechnology industry. This means that PLX’s stock grew similarly to IOVA’s over the last 12 months.

PLX's P/E Growth Rating (98) in the Servicestothe Health Industry industry is in the same range as IOVA (100) in the Biotechnology industry. This means that PLX’s stock grew similarly to IOVA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IOVAPLX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
78%
Bearish Trend 2 days ago
83%
Momentum
ODDS (%)
Bearish Trend 2 days ago
83%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 6 days ago
78%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
Bullish Trend 8 days ago
76%
Bullish Trend 3 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 16 days ago
80%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
79%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
Bullish Trend 2 days ago
81%
View a ticker or compare two or three
Interact to see
Advertisement
IOVA
Daily Signal:
Gain/Loss:
PLX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACNFF29.51N/A
N/A
Amsterdam Commodities N.V.
GBERF793.00N/A
N/A
Geberit AG
HRFEF0.06N/A
N/A
Harfang Expl Inc.
WPPGF4.45N/A
N/A
WPP PLC
SOBS29.00-0.17
-0.58%
Solvay Bank (NY)

IOVA and

Correlation & Price change

A.I.dvisor indicates that over the last year, IOVA has been loosely correlated with CLDX. These tickers have moved in lockstep 45% of the time. This A.I.-generated data suggests there is some statistical probability that if IOVA jumps, then CLDX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IOVA
1D Price
Change %
IOVA100%
-2.08%
CLDX - IOVA
45%
Loosely correlated
+1.01%
KURA - IOVA
44%
Loosely correlated
+0.44%
PLX - IOVA
44%
Loosely correlated
-3.81%
VCYT - IOVA
43%
Loosely correlated
-0.92%
IDYA - IOVA
42%
Loosely correlated
-4.75%
More

PLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PLX has been loosely correlated with IOVA. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if PLX jumps, then IOVA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PLX
1D Price
Change %
PLX100%
-3.81%
IOVA - PLX
44%
Loosely correlated
-2.08%
ADMA - PLX
33%
Loosely correlated
-1.28%
STOK - PLX
31%
Poorly correlated
+3.94%
ZNTL - PLX
31%
Poorly correlated
-0.29%
CPRX - PLX
31%
Poorly correlated
-3.75%
More